| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Canada | 2 | |
| #5 | Brazil | 1 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Organic fine chemistry | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Heterocyclic compounds | |
| #5 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Campbell Anthony Stewart | 12 |
| #2 | Donabedian David H | 7 |
| #3 | Mazmanian Sarkis | 5 |
| #4 | Campbell Anthony | 5 |
| #5 | Sampson Timothy | 4 |
| #6 | Bartolozzi Alessandra | 3 |
| #7 | Cole Bridget | 3 |
| #8 | Barrett Ryan | 2 |
| #9 | Bhagat Hitesh | 1 |
| #10 | Donabedian David | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020227437A1 | Sustained release solid dosage forms for modulating the colonic microbiome | |
| EP3664822A1 | Inhibitors of microbially induced amyloid | |
| WO2019027929A1 | Methods and apparatus for determining risk of autism spectrum disorder | |
| US2020163933A1 | Inhibitors of microbially induced amyloid | |
| CA3095724A1 | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders |